Tryptophan reduces creatine kinase activity in the brain cortex of rats

International Journal of Developmental Neuroscience

Volumn 22, Issue 2, 2004, Pages 95-101

  Cornelio, Andrea Renata ^a   Rodrigues Jr , Valnês ^a   De Souza Wyse, Angela Terezinha ^a   Dutra Filho, Carlos Severo ^a   Wajner, Moacir ^a   Wannmacher, Clovis Milton Duval ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Creatine kinase; Hypertryptophanemia; Tryptophan

Indexed keywords

CREATINE KINASE; KYNURENINE; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; HYPERTRYPTOPHANEMIA; IN VITRO STUDY; IN VIVO STUDY; METABOLIC DISORDER; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

RATTUS NORVEGICUS;

EID: 1342329453     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2003.12.004     Document Type: Article

References (43)

1. Aksenov M., Aksenova M., Butterfield A.D., Markesbery W.R. Oxidative modification of creatine kinase BB in Alzheimer's disease brain. J. Neurochem. 74:2000;2520-2527.
2. Aksenov M.Y., Aksenova M.V., Payne R.M., Smith C.D., Markesbery W.R., Carney J.M. The expression of creatine kinase isoenzymes in neocortex of patients with neurodegenerative disorders: Alzheimer's and Pick's disease. Experim. Neurol. 146:1997;458-465.
3. Aksenova M.V., Aksenov M.Y., Payne R.M., Trojanovski J.Q., Schmidt K.L., Carney J.M., Butterfield D.A., Markesbery W.R. Oxidation of cytosolic proteins and expression of creatine kinase BB in frontal lobes of neurodegenerative disorders. Dement. Geriatr. Cogn. Disord. 10:1999;158-165.
4. Arstall M.A., Bailey C., Gross W.L., Bak M., Balligand J.L., Kelly R.A. Reversible S-nitrosation of creatine kinase by nitric oxide in adult rat ventricular myocytes. J. Mol. Cell. Cardiol. 30:1998;979-988.
5. Brustovetsky N., Brustovetsky T., Dubinsky J.M. On the mechanisms of neuroprotection by creatine and phosphocreatine. J. Neurochem. 76:2001;425-434.
6. Burmistrov S.O., Mashek O.P., Kotin A.M. The action of acute alcoholic intoxication on antioxidant system and creatine kinase activity in the brain of rat embryos. Eksp. Klin. Farmakol. 55:1992;54-56.
7. Costabeber E., Kessler A., Dutra-Filho C.S., Wyse A.T.S., Wajner M., Wannmacher C.M.D. Hyperphenylalaninemia reduces creatine kinase activity in the cerebral cortex of rats. Int. J. Dev. Neurosci. 21:2003;111-116.
8. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem. J. 341:1999;233-249.
9. David S.S., Shoemaker M., Haley B.E. Abnormal properties of creatine kinase in Alzheimer's disease brain: correlation of reduced enzyme activity and active site photolabelling with aberrant cytosol-membrane partitioning. Mol. Brain Res. 54:1998;276-287.
10. Domingues M.R.M., Domingues P., Reis A., Fonseca C., Amado F.M.L., Ferrer-Correia A.J.V. Identification of oxidation products and free radicals of tryptophan by mass spectrometry. J. Am. Soc. Mass Spectrom. 14:2003;406-416.
11. Feksa L.R., Cornelio A.R., Vargas C.R., de Souza Wyse A.T., Dutra-Filho C.S., Wajner M., Wannmacher C.M. Alanine prevents the inhibition of pyruvate kinase activity caused by tryptophan in cerebral cortex of rats. Metab Brain Dis. 18(2):2003;129-137.
12. Foster A.C., Vezzani A., French E.D., Schwarcz R. Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid. Neurosci. Lett. 48:1984;273-278.
13. Gross W.L., Bak M.I., Ingwall J.S., Arstall M.A., Smith T.W., Balligand J.L., Kelly R. Nitric oxide inhibits creatine kinase and regulates heart contractile reserve. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5604-5609.
14. Hemmer W., Wallimann T. Functional aspects of creatine kinase in brain. Dev. Neurosci. 15:1993;249-260.
15. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenova M.V., Aksenov M.Y., Gabbita S.P., Carney J.M., Lowell M., Markesbery W.R., Butterfield D.A. Brain regional correspondence between Alzheimer's disease histopathology biomarkers of protein oxidation. J. Neurochem. 65:1995;2146-2156.
16. Hughes B.P. A method for estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin. Chim. Acta. 7:1962;597-603.
17. Kessler A., Costabeber E., Dutra-Filho C.S., Wyse A.T.S., Wajner M., Wannmacher C.M.D. Proline reduces creatine kinase activity in the brain córtex of rats. Neurochem Res. 28:2003;1175-1180.
18. Kroemer G., Dallaporta B., Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60:1998;619-642.
19. Konorev E.A., Hogg N., Kalyanaraman B. Rapid and irreversible inhibition of creatine kinase by peroxynitrite. FEBS Lett. 427:1998;171-174.
20. b-CK). Biochem. J. 344:1999;413-417.
21. Koufen P., Stark G. Free radical induced inactivation of creatine kinase: sites of interaction, protection, and recovery. Biochim. Biophys. Acta. 1501:2000;44-50.
22. Levy, H.L., 2001. Hartnup disorder. In: Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D. (Eds.): The Metabolic & Molecular Bases of Inherited Diseases, 8th ed. McGraw-Hill, New York, pp. 1667-1724.
23. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
24. Manos P., Bryan G.K., Edmond J. Creatine kinase activity in postnatal rat brain development and in cultured neurons, astrocytes, and oligodendrocytes. J. Neurochem. 56:1991;2101-2107.
25. Martin I.R., Mellor C.S., Fraser F.C. Familial hypertryptophanemia in two siblings. Clin. Gen. 47:1995;180-183.
26. Morgane J.P., Mokler D.J., Galler J.R. Effect of prenatal protein malnutrition on the hippocampal formation. Neurosci. Behav. Rev. 26:2002;471-483.
27. O'Gorman, E., Beutner, G., Dolder, M., Korestsky, A.P., Brdicska, D., Wallimann, T., 1997. FEBS Lett. 414, 253-257.
28. Pilla C., Cardoso R.F.O., Dutra-Filho C.S., Wyse A.T.S., Wajner M., Wannmacher C.M.D. Effect of leucine administration on creatine kinase activity in rat brain. Metab. Brain Dis. 18:2003;17-25.
29. Saks V.A., Ventura-Clapier R., Aliev M.K. Metabolic control and metabolic capacity: two aspects of creatine kinase functioning in the cells. Biochim. Biophys. Acta. 1274:1996;81-88.
30. Santus R., Patterson L.K., Filipe P., Morlieri P., hug G.L., Fernandes A., Maziere J.C. Redox reactions of the urate radical/urate couple with the superoxide radical anion, the tryptophan neutral radical and selected flavonoids in neutral aqueous solution. Free Radic Res. 35:2001;129-136.
31. Schlattner U., Wallimann T. Octamers of mitochondrial creatine kinase isoenzymes differ in stability and membrane binding. J. Biol. Chem. 275:2000;17314-17320.
32. Snedden W., Mellor C.S., Martin J.R. Familial hypertryptophanemia, tryptophanuria and indolketonuria. Clin. Chim. Acta.131:1983;247-256.
33. Stachowiak O., Dolder M., Wallimann T., Richter C. Mitochondrial creatine kinase is a prime target of peroxynitrite-induced modification and inactivation. J. Biol. Chem. 273:1998;16694-16699.
34. Stone T.W., Connick J.H. Quinolinic acid and other kynurenines in the central nervous system. Neuroscience. 15:1985;597-617.
35. Stuart-Audette M., Blouquit Y., Faraggi M., Sicard-Roselli C., Houee-Levin C., Jolles P. Re-evaluation of intramolecular long-range electron transfer between tyrosine and tryptophan in lysozymes. Evidence for the participation of other residues. Eur. J. Biochem. 270:2003;3565-3571.
36. Tada K., Ito H., Wada Y., Arakawa T. Congenital tryptophanuria with dwarfism ("H" disease-like clinical features without indicanuria and generalized aminoaciduria): a probably new inborn error of tryptophan metabolism. Tohoku J. Exp. Med. 80:1963;118-134.
37. Tarnopolsky M.A., Beal M.F. Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders. Ann. Neurol. 49:2001;571-594.
38. Tomimoto H., Yamamoto K., Homburger H.A., Yanagihara T. Immunoelectron microscopic investigation of creatine kinase BB-isoenzyme after cerebral ischemia in gerbils. Acta Neuropathol. 86:1993;447-455.
39. Wallimann T., Dolder M., Schlattner U., Eder M., Hornemann T., O'Gorman E., Ruck E., Brdiczka D. Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology. Biofactors. 8:1998a;229-234.
40. Wallimann T., Dolder M., Schlattner U., Eder M., Hornemann T., Kraft T., Stolz M. Creatine kinase: an enzyme with a central role in cellular energy metabolism. MAGMA. 6:1998b;116-119.
41. Wallimann T., Wyss M., Brdiczka D., Nicolay K. Intracellular compartmentation, structure and function of creatine kinase in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem. J. 281:1992;21-40.
42. Watanabe S., Togashi S., Takahashi N., Fukui T. L-J P, tryptophan as an antioxidant in human placenta extrat. J. Nutr. Sci. Vitaminol. (Tokyo). 48:2002;36-39.
43. Wolosker H., Panizzutti R., Engelender S. Inhibition of creatine kinase by S-nitrosoglutathione. FEBES Lett. 392:1996;274-276.